comprehensive -WSS

comprehensive

author：Wikipedia 2025-10-02 12:32:28 - browse：3

Dolly sheep — Alex Hogan/STAT, Getty Images

Dolly, the first animal to be cloned from an adult of its species, was born 20 years ago today at the Roslin Institute in Scotland. When her creators announced what they had done, it triggered warnings of rich people cloning themselves for spare parts, of tyrants cloning soldiers for armies, of bereaved parents cloning their dead child to produce a replacement — and promises that the technique would bring medical breakthroughs. Which raises some questions:

Why are there no human clones?

Because of scientific, ethical, and commercial reasons.

The scientists who created Dolly — named after Dolly Parton, naturally — removed the DNA from a sheep ovum, fused the ovum with a mammary epithelial cell from an adult “donor” sheep, and transplanted the result, now carrying DNA only from the donor, into a surrogate ewe. But that technique, called somatic cell nuclear transfer (SCNT), turned out not to be so easy in other species.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Experimental asthma app from Apple and Anthem shows promise

focus

WSS

Physician subsidies by hospitals soar in wake of No Surprises Act

First transplant of an entire human eye performed

How state and local governments are sidelining science

The FDA weighs the risks of candy

Testing for cancer recurrence creates a new limbo for patients

Carbon Health diabetes program, a test of data

explore

comprehensive

Why are there no human clones?

leisure time

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

Moonlake's readout produced a cash windfall. Risks remain

Telehealth options flood the market as retailers push virtual care

In Memoriam: Notable people who died in 2023

Biden's order seeks to regulate AI risk without stifling innovation

After affirmative action ruling, medical educators look to 'holistic review'

After decades in use, heart stents finally beat placebo

The high cost of giving birth even with insurance

Ohio still needs to do more to protect the right to abortion

entertainment

WHO may add ‘noma' to its list of neglected tropical diseases

Why Sanofi got shellacked over its spinoff

Readout Newsletter: Zepbound, Valneva's vaccine, and more

UnitedHealth sued over use of algorithm in Medicare Advantage plans

How state and local governments are sidelining science

Biden's order seeks to regulate AI risk without stifling innovation

explore

focus

focus

hotspot